Scarica l'app Stockscreener
3.97
4.11%
-0.17
Dopo l'orario di chiusura:
3.99
0.02
+0.50%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.14
Aprire:
$4.15
Volume 24 ore:
1.65M
Relative Volume:
1.39
Capitalizzazione di mercato:
$264.11M
Reddito:
$488.00K
Utile/perdita netta:
$-41.44M
Rapporto P/E:
-4.2688
EPS:
-0.93
Flusso di cassa netto:
$-31.47M
1 W Prestazione:
-7.24%
1M Prestazione:
+28.06%
6M Prestazione:
+16.42%
1 anno Prestazione:
+67.86%
Intervallo 1D:
$3.84
$4.1866
Intervallo di 1 settimana:
$3.73
$4.52
Portata 52W:
$2.01
$5.6395
Cardiff Oncology Inc Stock (CRDF) Company Profile
Nome
Cardiff Oncology Inc
Settore
Industria
Telefono
858-952-7570
Indirizzo
11055 FLINTKOTE AVENUE, SAN DIEGO, CA
Confronta CRDF con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRDF
Cardiff Oncology Inc
|
3.97 | 275.42M | 488.00K | -41.44M | -31.47M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Cardiff Oncology Inc Stock (CRDF) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-08 | Iniziato | Ladenburg Thalmann | Buy |
| 2025-06-24 | Iniziato | Jefferies | Hold |
| 2024-09-06 | Iniziato | Craig Hallum | Buy |
| 2022-01-05 | Iniziato | William Blair | Outperform |
| 2021-12-08 | Iniziato | Robert W. Baird | Outperform |
| 2021-08-09 | Ripresa | Maxim Group | Buy |
| 2020-10-22 | Iniziato | H.C. Wainwright | Buy |
| 2020-10-08 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Cardiff Oncology Inc Borsa (CRDF) Ultime notizie
What is the risk reward ratio of investing in Cardiff Oncology Inc. stockBuild a portfolio that outperforms the market - jammulinksnews.com
Why is Cardiff Oncology Inc. stock attracting strong analyst attentionPowerful market insights - jammulinksnews.com
How volatile is Cardiff Oncology Inc. stock compared to the marketTransform your portfolio with high-yield stocks - jammulinksnews.com
How strong is Cardiff Oncology Inc. company’s balance sheetUnlock superior stock analysis tools - jammulinksnews.com
What catalysts could drive Cardiff Oncology Inc. stock higher in 2025Invest smarter with high-probability setups - jammulinksnews.com
Should I hold or sell Cardiff Oncology Inc. stock in 2025Build wealth faster with high-performing stocks - jammulinksnews.com
When is Cardiff Oncology Inc. stock expected to show significant growthRealize exceptional returns through smart trading - jammulinksnews.com
Is Cardiff Oncology Inc. stock a growth or value playFree Stock Market Courses - Newser
New Product Launches: Will They Boost Cardiff Oncology Inc. Stock in 2025Free Investment Portfolio Suggestions - Newser
How Interest Rate Changes Impact Cardiff Oncology Inc. Stock PerformanceFree Join Group - Newser
How Cardiff Oncology Inc. stock performs during market volatilityFree Stock Index Interpretation - Newser
Is Cardiff Oncology Inc. Stock Overbought or Oversold RSI Indicator AnalysisHigh Confidence Trade Setups - Newser
Cardiff Oncology Inc. Company’s Quarterly Earnings Growth: What the Numbers SayProfit Focused Trade Alerts - Newser
Is Cardiff Oncology Inc. a good long term investmentHigh-octane investment gains - PrintWeekIndia
Published on: 2025-07-25 15:19:32 - PrintWeekIndia
What analysts say about Cardiff Oncology Inc. stockExplosive capital appreciation - Autocar Professional
Cardiff Oncology Inc. Stock Analysis and ForecastExplosive trading opportunities - Autocar Professional
What drives Cardiff Oncology Inc. stock priceFast-track wealth growth - jammulinksnews.com
What makes Cardiff Oncology Inc. stock price move sharplyFree Day Trading Recommendations - Newser
Cardiff Oncology: Volatility Afoot With Onvansertib Update Near-Term (NASDAQ:CRDF) - Seeking Alpha
Why Cardiff Oncology Inc. stock attracts strong analyst attentionAlpha Stock Ideas - Newser
Cardiff Oncology Inc Azioni (CRDF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):